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Abstract
Invalidation is defined as the perception of cognitive, affective, and behavioral responses of
others that are experienced as denying, lecturing, overprotecting, not supporting, and not
acknowledging with the respect to the condition of the patient (Kool, 2012). Invalidation has also
been suggested to negatively impact patients’ physical health (Kool, 2012). One specific type of
invalidation is illness invalidation (II), defined as attitudes of distrust, suspicion, lack of support
for, or acknowledgement that a patient is suffering from an illness (Blom et al., 2011). In
addition to II, illness perception (IP) is another construct that has been linked to negative
physical health (Arran, Carufurd, & Simpson, 2013). IP is a process through which an individual
constructs a cognitive representation of an illness and has also been shown to influence symptom
severity and physical functioning (Arran et al., 2013). Although the relationships between II, IP,
and physical health have been observed previously, more extensive research is needed to
determine the specific mechanisms of these relationships and what other psychological factors
may play a role. Previous studies indicate that coping behaviors and depressive symptoms may
be factors that influence these relationships (Shen, McCreay, & Myers, 2003). The present study
used a regression analysis to reveal that depression was the only significant predictor of physical
functioning. The present study also used PROCESS (Hayes, 2013) to reveal that depression
mediated the relationship between IP and physical functioning, but did not mediate the
relationship between II and physical functioning. The present study also revealed that coping did
not mediate the relationship between IP and physical functioning, nor did coping mediate the
relationship between II and physical functioning. Lastly, the present study revealed that II and IP
were both significantly related to depression, and IP was significantly related to II.
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Examining II and IP in Relation to Physical Functioning in the Context of Cardiovascular
Disease
Cardiovascular disease is currently the leading global cause of death, accounting for 17.3
million deaths per year (American Heart Association, 2015). Since 1921, cardiovascular disease
has been the leading cause of death in the United States and currently accounts for over 375,000
American deaths per year (Howarter, Bennett, Barber, Gessner, & Clark, 2014). By the year
2020, the World Health Organization predicts that cardiovascular disease and major depression
will become the two leading contributors to the global burden of disease, and that cardiovascular
disease alone will account for more than 23.6 million deaths per year by the 2030 (Ali, Rollman,
& Berger, 2010). A widespread amount of recent literature has established that psychosocial
factors significantly contribute to the pathogenesis of coronary artery disease (Rozanski,
Blumenthal, & Kaplan, 2014). The prevalence of comorbid mental health conditions in cardiac
patients is well documented with many studies associating psychological risk factors with a poor
prognosis for heart diseases (Ali et al., 2010). This extensive knowledge has also contributed to
the illumination of the basic pathophysiology that underlies the relationship between
psychosocial factors and development and severity of heart disease (Rozanski et al., 2014).
However, the identification of psychological predictors for coronary heart disease has produced
inconsistent results (Rugulies, 2002). Despite many encouraging findings, there has been
insufficient research exploring the interrelationships among some of these conceivable related
psychosocial variables and how they may affect the outcomes of coronary heart disease (Shen et
al., 2003).
Depression and Cardiovascular Disease Prognosis
Perhaps the most widely studied psychosocial factor in relation to cardiovascular disease
is depression. In this paper, depression refers to unipolar clinical depression as diagnosed by
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clinical assessment, and depressed mood as measured by standardized self-report scale.
Depression has been found to be an independent risk factor in the etiology of coronary heart
disease and the risk of coronary heart disease has been found to be directly related to the severity
of depression (Goldston & Baillie, 2008). Comorbid depression is relatively common in patients
with coronary heart disease, as approximately one in five patients with newly diagnosed heart
disease has major depression (Carney, Freedlan, Miller, & Jaffe, 2002). The prevalence of major
depression is similar in patients recovering from acute myocardial infarction and other acute
cardiac stresses and once coronary heart disease is established, depression has a negative overall
impact on the prognosis of the disease, increasing both the risk of occurrence of future cardiac
events and higher risk of mortality (Goldston & Baillie, 2008). The presence of depressive
symptoms even in the absence of diagnosed major depressive episodes is associated with
increased risk for cardiac events, and a number of studies confirm a relationship between the
magnitude of depression and future cardiac events (Rozanski et al., 2014). This data suggests
that risk for future cardiac disease associated with depression exists along a continuum relative to
the magnitude of depressive symptoms (Rozanski et al., 2014).
There are many proposed mechanisms to explain the relationship between depression and
severity of physical symptoms in patients with cardiac disease. Some plausible explanations for
the relationship between depression and cardiac mortality and morbidity include biological
mechanisms such as antidepressant cardiotoxicity and dysregulation of autonomic,
neuroendocrine, and seratonergic systems (Carney et al., 2002). More specifically, depression
has been associated with hyperactivity of the hypothalamic-pituitary-adrenocortical (HPA) axis,
which results in over-stimulation of the sympathetic nervous system, which then increases
circulating catecholamines and serum cortisol (Goldston & Baillie, 2008). These neurohormonal
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abnormalities contribute to an imbalance in sympathetic and parasympathetic activity, which
results in surges in heart rate and systolic blood pressure, increasing the risk of atherosclerotic
plaque rupture and acute coronary thrombosis (Goldston & Baillie, 2008).
According to Rozanski et al. (2014), direct pathophysiological effects of depression
involve at least three mechanisms. The first is that depression is accompanied by
hypercortisolemia, which is associated with attenuation of the adrenocorticotropin hormone
response to corticotropin-releasing factor administration, non-suppression of cortisol secretion
after dexamethasone administration, and elevated corticotropin releasing factor concentrations in
the cerebrospinal fluid, all of which contribute to more severe symptoms of heart disease. A
second mechanism proposed by Rozanski et al. is that due to the association between depression
and unhealthy lifestyle behaviors, depressed patients may develop substantial impairment in
platelet function. This impairment can include augmented platelet reactivity and release of
platelet products including platelet factor 4 and b-thromboglobulin, which are associated with
adverse cardiovascular events. The mixture of hypercortisolemia and enhanced platelet function
establishes the theoretical basis to explain the proatherogenic effects of depression (Rozanski et
al., 2014). Lastly, reduced heart rate variability (HRV) and impaired vagal control have been
reported in cardiac patients suffering from depression. HRV is a widely used noninvasive
measure that reflects the autonomic regulation of the heart and is measured by beat-to-beat
changes in a patient’s heart rate (Hoogwegt et al., 2014). Reduced HRV is a well-known
predictor of cardiac mortality, including sudden cardiac death resulting from ventricular
fibrillation. This finding also supports the assertion that depressed patients may be subject to
increased risk for cardiac arrhythmia, further contributing to severity of cardiac related

II AND IP IN THE CONTEXT OF CARDIOVASCULAR DISEASE

6

symptoms. Therefore, HRV might be an important explaining mechanism of the relationship
between psychological distress and prognosis (Hoogwegt et al., 2014).
Depression may also contribute to the onset or worsening of cardiovascular disease by
triggering recurrent endothelial injuries (Carney et al., 2002). The endothelium is the key
regulator of homeostasis in the vascular tissue, and alteration in endothelial function precedes the
development of atherosclerosis in patients (Deanfield, Halcox, & Rabelink, 2015). This could
occur via promotion of maladaptive health processes, triggering dysregulation of the
neurohormonal systems responsible for cortisol and catecholamine secretion, or increasing
susceptibility to infection with latent pathogens that colonize the vessel wall (Herbert & Cohen,
1993; Miller, Cohen, & Herbert, 1999; Plotsky, Owens, & Nemeroff, 1995). Furthermore, in
consideration of behavioral mechanisms, depression is associated with unhealthy lifestyle
behaviors including smoking and poor compliance with medication, which have been shown to
contribute to the worsening function of these biological processes and, thus, increased rates of
morbidity and mortality in patients with cardiovascular disease (Rozanski et al., 2014). In order
to investigate the relationship between depression and physical function in the present study, a
regression analysis was used.
Coping and Cardiovascular Disease Prognosis
As previously mentioned, psychological interventions for cardiac patients have mostly
focused on depression factors, selecting patients for treatment based on the type and severity of
symptoms displayed (Chiavarino et al., 2012). One general shortcoming of all symptom-based
approaches is that they do not address, and are not concerned with, the ways that individuals
attribute meaning to the events that happen to them. Research findings indicate that the wellbeing of chronically ill patients is not only determined by medical factors such as disease
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severity, but that psychological factors such as coping strategies patients adopt play a crucial role
in physical recovery (Kaptein et al., 2006). Penninx et al. (1998) revealed that personal coping
resources were directly associated with less depressive symptoms in patients. Furthermore,
Hoogwegt et al. (2013) found that emotional distress that results from an inability to cope has
been associated with cardiac events and poor prognosis in cardiovascular patients. In patients
with coronary artery disease, emotional distress is known to increase the risk of ventricular
arrhythmias and mortality independent of biomedical risk factors (Hoogwegt et al., 2013).
In contrast to symptom-based treatment approaches, constructive approaches emphasize
the structure of human experience and focus on the emotions, thoughts, and behavioral strategies
that lead an individual to develop a certain symptom rather than on the symptom itself
(Chiavarino et al., 2012). In other words, constructive approaches focus on specific coping
strategies that may lead to depressive symptomatology, and thus the severity of cardiac
symptoms. Consistent with this way of thinking, it has been demonstrated that coping strategies
following a cardiac event can influence psychological well-being or distress (i.e., depression),
perceived quality of life, and health-related behaviors, which can in turn influence the severity of
the patient’s cardiovascular disease (Chiavarino et al., 2012).
Coping with illness involves both cognitive and behavioral efforts to manage the external
or internal demands that are appraised as taxing or surpassing individual resources (Fan, Eiser,
Ho, & Lin, 2012). There are two kinds of coping behaviors that have been defined: problemfocused coping, a behavior in which the individual attempts to manage the stressor or solve the
problem, and emotion-focused coping, a behavior in which the individual attempts to regulate
the emotional response that is induced by the stressor (Folkman et al., 1986). People tend to use
problem-focused approaches when they believe that their resources or the demands of the
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situation are changeable, and people tend to use emotion-focused coping when they believe they
can do little to change the stressful conditions (Sarafino & Smith, 2011). However, some coping
strategies can ultimately have negative effects. For example, avoidance as an emotion-focused
coping strategy is a specific emotional coping behavioral technique in which the individual
attempts to avoid dealing with the stressor at all. This strategy can be helpful for the individual in
the short-term, but using avoidance strategies to cope two to three weeks after the stressor
occurred has been associated with higher levels of emotional distress (Dunkel-Schetter,
Feinstein, Taylor, & Falke, 1992). Emotional coping strategies that acknowledge the stressor,
including positive reappraisal and actively processing emotions, have been found to be
associated with an overall trend of better adaptation and management of problems in individuals
(Fan et al., 2012).
It has been suggested in the cardiological field that emotion-focused coping strategies
which are directed at managing one’s emotional reactions to a stressor or event are especially
important and effective in the time following a cardiac event (Chiavarino et al., 2012).
Chiavarino et al. (2012) found emotion-focused coping strategies at the time of a cardiac event
were a reliable predictor of disease severity at a three-month follow up. Sul and Fletcher (1985)
also found that active problem-focused coping was found to result in more benign long-term
outcomes. Another study found that avoidant coping was associated with a widespread
psychological distress among cardiac patients, including depression (Ali et al., 2010). Behavioral
research has also shown that hope and adaptive coping can help alleviate symptoms and improve
outcomes in patients with cardiac disease (Ali et al., 2010). Demonstrating that patients’ coping
strategies after a cardiac event are more strongly associated with future disease severity than
expressed symptomatology supports an emphasis on individuals using the constructive
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perspective to make sense of the events that happen to them and deal with these events
(Chiavarino et al., 2012). Consistent with the previously mentioned analysis method used to
investigate the relationship between depression and physical function, a regression analysis was
also used in the present study in order to investigate the relationship between coping and
physical functioning in a cardiac rehabilitation population.
Invalidation and Cardiovascular Disease Prognosis
A copious amount of literature has revealed that in addition to personal coping resources,
social support may also contribute to variability in the impact of chronic illness (Penninx et al.,
1998). The robust association of social support and health status has been well-documented
(Case et al., 2002). In a study of depression among patients in cardiac rehabilitation, Holohan et
al. (1997) found that more perceived social support was associated with active coping, which in
turn was related to lower depressive symptomatology. Depressed patients have also been found
to be less likely to utilize social support resources available to them (Berkman, 1995). As
previously mentioned, depressive symptomatology in turn was associated with worse health
outcome in cardiac patients and an increased likelihood of experiencing angina, maintaining
smoking habits, and a failure to return to work (Shen, McCreary, & Myers, 2003). Shen et al.
(2003) discovered that social support was a direct independent predictor of post-treatment
physical functioning in cardiac rehabilitation patients. Individuals with higher perceived social
support were less likely to engage in detrimental coping and experienced less mood disturbance.
Social support, like many other psychosocial factors, influences the extent to which
individuals engage in high risk behaviors and maladaptive coping mechanisms such as smoking,
poor diet, and excessive alcohol use (Penninx et al., 1998). Social support factors have also been
shown to have direct pathophysiological effects (e.g., hypercortisolemia; Rozanski et al., 1999).
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Initial studies focused on the quantitative aspects of social support, including the presence of
family affiliations, amount of friends, and scope of participation in a group or organization
(Rozanski et al., 1999). However, the qualitative nature of social support (i.e., perceived amount
of social support) has been increasingly subject to study.
The support received from others can be fundamental in helping to improve the quality of
life in patients suffering from chronic disease (Kool, 2012). People are social beings for whom
positive interactions as well as supportive communication are important. In other words, people
hold a deep-seated need to belong and to be socially accepted (Bediako & Friend, 2004).
However, many patients not only experience a lack of social support, but a lack of understanding
as well. In these cases, people in the social environment may accuse the patient of being whiny
or exaggerating the severity of his or her symptoms, and may tell the patient that (s)he should
work harder, stop complaining, and feel better. In this case, the term invalidation is used to
capture the construct that refers to such negative rejections (Kool, 2012).
It is important to note that invalidation is not simply the opposite of social support.
Invalidation is a social phenomenon that is determined by not only the provider of the
invalidation, but the perceiver as well. Several studies have shown that invalidation may arise
from different sources, including spouses, colleagues, health professionals, and society, and can
hinder the interaction of patients with other people (Ghavidel-Parsa et al., 2014). Invalidation can
be reflected in an individual’s overall perception of emotional, behavioral, and cognitive
responses from others. Kool et al. (2012) also found that from the perspective of the patients,
invalidation not only includes lack of understanding and denying, but also lecturing and
overprotecting. Therefore, invalidation can be more specifically defined in a healthcare setting as
“the perception of cognitive, affective, and behavioral responses of others that are experienced as
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denying, lecturing, overprotecting, not supporting, and not acknowledging with respect to the
condition of the patient” (Kool et al., 2012, p.30).
II is one type of invalidation that plays a role in patients’ overall health status. II can be
defined as attitudes of distrust, suspicion, lack of support for, or acknowledgement that a patient
is suffering from an illness (Blom et al., 2011). Lobo et al. (2014) suggested that constant
invalidation of symptoms may serve as a barrier in effective management of pain and its
associated symptoms, and may also interfere with shared decision making processes regarding
patient treatment. Due to complexity and variance of many symptoms of chronic illness, the
process of diagnosis and treatment can be frustrating for patients as well as physicians. Previous
studies have indicated that patients suffering from chronic illness could benefit from empathy,
trust, and recognition of their disorder (Blom et al., 2011). Invalidation of the illness and
symptoms can cause disbelief about the patient’s presenting problems, which can result in
misunderstanding, rejecting, and discounting by others and suspicion that the symptoms are
either exaggerated or have a psychological basis (Ghavidel-Parsa et al., 2014). Previous studies
have also provided evidence that fewer experiences of II have been associated with a higher
quality of life for patients, which can result in less severe depressive symptoms (Lobo et al.,
2014). Research suggests that II can also weaken a patient’s ability to solve interpersonal and
emotional difficulties, which can affect their overall quality of life (Blom et al., 2011). Study
findings from Lobo et al. (2014) also demonstrate that II may have a detrimental effect on health
outcomes and overall quality of life. This study specifically showed that invalidation of patients’
physical symptoms could have an impact on self-development, relationships with others, and
interactions with society, which may further manifest into depressive symptoms and impact
physical functioning.
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It is suggested that in addition to having a negative effect on mental well-being,
invalidation may impact physical health and social function (Ghavidel-Parsa et al., 2014). It also
has been shown to decrease social support and increase social rejection (Kool et al., 2009).
According to social support theory, social support advances health and buffers the impact of
external stressors on health, implying that a lack of social support may be associated with worse
health (Bediako & Friend, 2004). These findings suggest that invalidation would have a negative
impact on patients’ health as well, as invalidation is not only a lack of social support, but overt
rejection and not being acknowledged. This invalidation is in direct contrast to having social
support where one would receive positive and helpful responses such as affection, information,
instrumental aid, and spending positive time with others (Laidmäe, Leppik, Tulva, & Hääl,
2009). In fact, it has been suggested that invalidation might be more harmful than not receiving
social support in patients, because invalidation can lead to higher levels of non-disclosure of the
illness, social isolation, a decrease of health care adherence and treatment, and changes in
cognition that may affect a patient’s health (Rokach, Lechcier-Kimel, & Safarov, 2006).
Therefore, besides simply a lack of positive social interactions, invalidation may have a
complementary negative effect on patients’ well-being and overall physical functioning (Kool,
2012).
Further evidence indicates that more discounting by a patient’s social network may be
associated with worse mental well-being and worse physical functioning, and that the more
invalidation patients experience, the greater the disease impact and the greater the symptom
severity (Ghavidel-Parsa et al., 2014). Invalidation includes a lack of positive social responses,
and these positive social responses are thought to directly promote health and buffer the impact
of external stressors on health. Invalidation may also be harmful to patient’s health for additional
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reasons other than a lack of social support. Invalidation includes an active component of social
rejection, which has been indicated in past research to amplify pain via activation of neural
structures such as the anterior cingulated cortex (Kurzba & Leary, 2001). Research suggests that
focusing on patients’ perception of invalidation may lead to improvements in physical health,
and that experimental research should examine effects of not only promoting social support, but
decreasing invalidation (Kool, 2012).
The specific mechanisms of how II relates to worsening physical functioning continue to
remain unknown. However, it has been shown that patients who feel invalidated are more likely
to distance themselves from others and become socially isolated, which often leads to
depression, which has a known effect on the severity of physical functioning (Rokach et al.,
2006). Patients who experience invalidation also sometimes withdraw from traditional medical
care instead of adjusting to their illness (Kool, 2012). This avoidant coping has also been shown
to contribute to higher levels of emotional distress, and thus may contribute to worsening
physical symptoms. Consistent with the previously stated method of analyses used to investigate
the relationship between depression and physical function, and coping and physical function, a
regression analysis was also used in the present study in order to investigate the relationship
between II and physical functioning in a cardiac rehabilitation population.
IP and Cardiovascular Disease Prognosis
Another important psychological factor that may influence symptom severity and
physical functioning in cardiac patients is the level of IP. IP is a process through which an
individual constructs a cognitive representation of an illness and has also been shown to
influence symptom severity and physical functioning in cardiac patients (Arran, Carufurd, &
Simpson, 2013). According to the common sense model, patients actively process, understand,
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and interpret information related to their health status or illness (Fan, Eiser, Ho, & Lin, 2012).
Patients’ representations of their illness are based on beliefs about the following five
components: identity (referring to the label or nature of the condition), causal beliefs (beliefs
about the causes of their disease), timeline (duration of their disease), consequences (the impact
of their disease on their life), and cure (whether the disease is amenable to cure or control). There
are two parallel-processing pathways including cognitive representations and emotional
responses to their illness. Using these representations, patients plan and implement coping
behaviors in order to manage their health related problems (Fan et al., 2012).
Arran, Carufurd, and Simpson (2013) found that IPs were positive predictors of
depression and that IPs play a significant role in levels of psychological distress, thus
contributing to worsening physical symptoms. One model that is widely used in the field of
chronic illness that best illustrates the relationship between IP and depression is the selfregulation model. Self-regulation describes the process through which an individual constructs a
cognitive representation of an illness, selects a coping strategy in response to the perceived
threat, and evaluates its effectiveness and outcome (Arran et al., 2013). These representations
directly influence the coping behaviors utilized by the individual and, consequently, that
individual’s emotional response to the illness. In short, the self-regulation model postulates that
an individual chooses coping strategies based on their own perceptions of the illness. This
combination of IPs and coping strategies is thought to influence the person’s emotional reaction
to the illness, contributing to the level of psychological distress, such as depression (Arran et al.,
2013). As previously discussed, depressive symptomatology is an established predictor of a
worse prognosis and increased severity of symptoms in cardiac patients. This implies that coping
mechanisms selected by the patient based on his or her perception of the illness may be
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responsible for increased amounts of depressive symptoms, which may then negatively influence
the patient’s physical health.
Studies have shown that when patients perceived their disease to be controllable, the
majority used cognitive strategies such as reappraisal and problem-focused coping in order to
manage their problems (Kaptein et al., 2006). Patients who perceive that their disease will have a
low impact on their quality of life have been shown to have better adjustment outcomes to
coping with their disease (Hagger & Orbell, 2003). The interaction of problem-focused coping
and perceived control has also been found to be a significant predictor of depression, as patients
who perceived higher levels of control and used problem-solving coping had lower levels of
depression than those who did not (Osowiecky & Compas, 1998). However, the question still
remains whether IPs influence well-being via coping, or whether IPs and coping each influence
well-being independently (Kaptein et al., 2006). Consistent with all other previously mentioned
methods of analyses, a regression analysis was also used in the present study in order to
investigate the relationship between IP and physical functioning in a cardiac rehabilitation
population.
Present Study
In consideration of previous empirical evidence, the present study sought to better
understand the specific ways that II and IP contribute to the severity of physical symptoms in
cardiovascular rehabilitation patients. This study aimed to examine the specific mechanisms
involved in the relationship between II and physical functioning in cardiac rehabilitation patients
and the specific mechanisms involved in the relationship between IP and physical functioning in
cardiac rehabilitation patients. More specifically, the present study focused on how II and IPs are
each individually related to coping behaviors and depressive symptoms, and how those behaviors
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and symptoms relate to the patient’s physical functioning. The present study had two primary
goals: First, to identify the strength of the relationships between IP and physical functioning and
II and physical functioning upon enrollment in the rehabilitation program. Second, the present
study sought to identify the role, if any, that coping behaviors and depressive symptoms play in
these relationships. Thus, due to the comprehensive purpose of this study, the following
hypotheses were proposed:
Hypothesis 1: Physical functioning (as measured by a composite score of the SF-36,
heart rate, body mass index, and systolic blood pressure) will be significantly predicted by II
scores (as measured by scores on the Illness Invalidation Inventory), IP scores (as measured by
the Illness Perception Questionnaire), positive coping strategy scores (as measured by the Brief
Coping Orientation to Problems Experienced Inventory), and depression symptom severity
scores (as measured by the Center for Epidemiologic Studies Depression Scale-Revised). That is,
the severity of physical symptoms indicative of cardiac disease will be predicted by whether the
individual perceives his or her social environment to be invalidating of his or her illness, the
individual’s cognitive representation of the illness, whether the individual has used a positive
coping strategy to manage distress, and whether the individual experiences elevated symptoms of
depression. This hypothesis is based on previous research that has demonstrated a relationship
between physical functioning and invalidation (Ghavidel-Parsa et al., 2014), IPs (Arran et al.,
2013), positive coping behaviors (Kaptein et al., 2006), and depression (Goldston & Baillie,
2008).
Hypothesis 2: Coping mechanisms (as measured by the brief COPE) and depression
symptom severity (as measured by the CESD-R) will both mediate the relationship between
invalidation (as measured by scores on the 3*I) and physical functioning (as measured by a
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composite score of the SF-36, heart rate, body mass index, and systolic blood pressure) as well
as mediate the relationship between IP (as measured by the IPT) and physical functioning (as
measured by a composite score of the SF-36, heart rate, body mass index, and systolic blood
pressure). That is, the significance of the relationship between II and IP on physical functioning
will be influenced by coping style and severity of depressive symptoms. This hypothesis is based
on evidence that invalidation and IP appear to influence an individual’s coping style (Arran et
al., 2013; Holohan, 1997), which appears to influence the severity of an individual’s depressive
symptoms (Chiavarino et al., 2012), which appear to influence an individual’s level of physical
functioning (Goldston & Baillie, 2008). Despite the absence of direct effects in Hypothesis 1,
Hypothesis 2 was performed investigating mediation of all constructs in order to investigate
opposing processes; that is, to investigate whether the absence of direct effects is the result of
inconsistent mediation of other constructs involved (Murayama & Elliot, 2012).
Method
Participants
This study utilized participants from the Cardiac Rehabilitation program at the Wellness
Center of the University of South Carolina Aiken. A G*Power analysis revealed that in order to
achieve statistically significant results, data from 44 participants would be required, which was
achieved in the present study. Admission criteria for participation in the study consisted of the
following criteria: a) a recent cardiac trauma in the form of myocardial infarction, coronary
artery bypass graft surgery or percutaneous coronary intervention b) the ability to read at a level
commensurate with the self-report measures employed in the study; and c) enrollment in the
cardiac rehabilitation program. Rehabilitation members were not offered any compensation for
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participating in the study, since the study was a review of assessments gathered during the
rehabilitation program.
Routine Measures
Demographics Questionnaire (see Appendix A). A questionnaire was developed in order
to ascertain important demographic information about each participant (i.e., gender, age, ethnic
and cultural background, socioeconomic status, etc.) and the type of cardiac trauma experienced
that led to enrollment in the cardiac rehabilitation program. Demographic information was
assessed via forced-choice response options and the individual was asked to describe the cardiac
event experienced and the date at which it occurred in an open-ended response.
The 36-Item Short-Form Health Survey –3-month form SF-36; Ware & Sherbourne,
1992; see Appendix B). The SF-36 is a 36-item survey of patient health consisting of a multiitem scale that assesses eight health-related quality of life domains: limitations in physical
functioning, limitations in usual role functioning because of physical health problems, bodily
pain, general health perceptions, vitality, limitations in social functioning because of physical or
emotional problems, limitations in usual role functioning because of emotional health problems,
and general mental health. Each subscale contains statements relevant to a particular domain that
are rated differently, depending on the domain being measured. For instance, questions assessing
for limitations in physical activity are rated on a 3-point Likert scale where the individual is to
indicate whether one’s health limits one’s physical activities (e.g., 1 = yes, limited a lot, 2 = yes,
limited a little, 3 = no, not limited at all); in contrast, questions measuring vitality and mental
health are to be rated on a 6-point Likert scale where feelings are to be rated in frequency over
the past four weeks (e.g., 1 = all of the time, 2 = most of the time, 3 = a good bit of the time, 4 =
some of the time, 5 = a little of the time, 6 = none of the time). The SF-36 has elicited high
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internal consistency when used with patients suffering from a myocardial infarction with
Cronbach alphas ranging from .72 to .92 (Failde & Ramos, 2000). Under each of the eight
dimensions measured, item scores are coded, summed, and transformed to a scale ranging from 0
(worst health status) to 100 (best health status).
Scores on the SF-36 were combined with the patient’s heart rate, systolic blood
pressure, and body mass index data into one overall physical functioning composite score.
First, correlations were computed between all variables (Table 1). It is important to note
that the SF-36 was reverse coded in order to compute an accurate score for the items, and
thus is negatively correlated with the objective physical measures. Each raw score was then
standardized by converting it into a z-score, and the z-scores were then summed and
averaged in order to create a standardized composite for physical functioning that was
then used in subsequent analyses.
The Center for Epidemiologic Studies Depression Scale- Revised (CESD-R; Eaton, 2004;
Radloff, 1977; see Appendix C). The Center for Epidemiologic Studies Depression Scale is a 20item scale used to measure symptoms of depression in nine different groups as defined by the
American Psychiatric Association Diagnostic and Statistical Manual, fifth edition. Using a
forced-choice format, individuals were asked to rate on a 5-point Likert scale how often they
experience symptoms (e.g. 0 = not at all or less than 1 day, 1 = 1-2 days, 2 = 3-4 days, 3 = 5-7
days, and 4 = nearly every day for 2 weeks). These symptoms include sadness, loss of interest,
appetite, sleep, concentration, guilt, tiredness, movement, and suicidal ideation. The total CESDR score was calculated as a sum of responses to all 20 questions and was used in determination
of possible depressive symptom categories.
The Brief Illness Perception Questionnaire (Brief IPQ; Broadbent, Petrie, Main, &
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Weinman, 2006; see Appendix D). The Brief Illness Perception Questionnaire is a 9-item
standardized instrument developed in order to assess cognitive and emotional illness
representations. Eight items are rated on an 11-point (0-10) end-defined response scale. Five of
the items assess cognitive illness representations: “consequences” (Item 1), “timeline” (Item 2),
“the degree of personal control over the disease” (Item 3), “treatment control” (Item 4), and
“identity” (Item 5). Two of the items assess emotional representations: “concern” (Item 6) and
“emotional response” (Item 7), while one item assesses “illness understanding” (Item 8). High
scores gained on these dimensions represent strongly-held beliefs about more serious
consequences of the illness (Item 1), its more pronounced chronic nature (Item 2), stronger
positive beliefs in controllability of the illness (Item 3 and 4), a greater number of symptoms
attributed to the illness (Item 5), a higher level of patient’s emotional distress arising from the
illness (Item 6 and 7), and better personal understanding of the illness (Item 8).
The Brief Coping Orientation to Problems Experienced Inventory (Brief COPE; Carver,
1997; Muller & Spitz, 2003; see Appendix E). The Brief COPE is a short, multidimensional
inventory including 14 two-item scales that measure 14 conceptually differentiable coping
reactions. These strategies, which include adaptive as well as potentially problematic responses,
are acceptance, active coping, positive reframing, planning, using instrumental support, using
emotional support, behavioral disengagement, self-distraction, self-blame, humor, denial,
religion, venting, and substance use.
The Illness Invalidation Inventory (3*I; Kool et al., 2010; see Appendix F). The 3*I is a
40-item scale that assesses patients' perception of responses of others that are perceived as
denying, lecturing, not supporting and not acknowledging the condition of the patient across five
different sources. It assesses two internally consistent dimensions of invalidation: discounting
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and lack of understanding.
Duke Activity Status Index (DASI; Hlatky & Mark, 1989; see Appendix G).
The Duke Activity Status Inventory is a 12-item questionnaire developed to measure
functional status of the individual while also providing insight into selected aspects of quality of
life. This scale uses the individual’s capacity in daily living activities in order to gauge functional
capacity. These activities represent major aspects of physical functioning including: personal
care, ambulation, ability to carry out household tasks, ability to engage in recreational activities,
and ability to engage sexually. Participants were asked to indicate if and how well they could
engage in each task, given one of four options, (1 = Yes, with no difficulty, 2 = Yes, but with
some difficulty, 3 = No, I can’t do this, or 4 = Don’t do this for other reasons). The DASI has
elicited high internal consistency when used with patients who have chronic coronary disease,
with Cronbach alphas ranging from .81 to .89, while there were no statistically significant
differences for stable patients in the two-week re-test period (Alonso et al., 1997). For every item
listed on this measure, there is a corresponding weighted value (e.g., ability to walk around the
house = 1.75; ability to run a short distance = 8.00) used for scoring purposes. In order to score
the DASI, the total number of corresponding weighted values to all questions where the rater
answered one (Yes, with no difficulty) is summed. In order to get the estimated peak oxygen
uptake score, the summed number was entered into the following equation [0.43*(duke status
index)] 9.6 and then divided by 3.5 to convert it into metabolic equivalents. Scores on the DASI
may range from 0 – 52.8, with metabolic equivalent scores ranging from 0 – 9.89. Higher
metabolic equivalent scores are indicative of a more physically active person with a
corresponding higher functional capacity. In contrast, a low score on this measure indicates
significant deficits in the ability to engage in physical activity and an overall poorer quality of
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life.
State-Trait Anxiety Inventory-Y-2 Form (STAI; Spielberger, Gorsuch, Lushene,
Vagg, & Jacobs, 1983; see Appendix H). The STAI Y-Form serves as a measure of state (Y-1)
and trait (Y-2) anxiety, and assesses the overall severity of anxiety in adults. Individuals rate on a
4-point Likert scale how intensely they experience symptoms of anxiety at that moment while
taking the assessment (e.g., 1 = Not at all, 2 = Somewhat, 3 = Moderately so, 4 = Very much so)
and also generally speaking under normal circumstances (e.g., 1 = Almost never, 2 = Sometimes,
3 = Often, 4 = Almost always). The instrument is divided into two sections, with each form
having a total of twenty questions. The range of scores is 20-80, with a higher score indicating
greater anxiety. Some of the questions assess for the absence of anxiety and therefore must be
reverse-scored. For the purposes of this study, consistent with rehabilitation procedures, only the
trait (Y-2) form was used. The test-retest reliability of the STAI was reported by Spielberger and
colleagues (1970) to be .54 for the state measure and .86 for the trait measure. The STAI is
considered a valid scale, with Cronbach’s alphas ranging from 0.87- 0.92 (Van der Ploeg,
Defares, & Spielberger, 1970).
Procedure
All data was gathered from the cardiac rehabilitation program located at the USC Aiken
Wellness Center. Within their first six sessions enrolled in the program, all rehabilitation
participations were asked to complete routine assessments for the purposes of tracking
rehabilitation progress. Patients completed the measures with a rehabilitation assistant at the
cardiac rehabilitation facility. Patients were also given the option to take measures home with
them to complete and return at their next session if they began to feel overwhelmed or fatigued.
These routine assessments included the one-year 36-Item Short Form Health Survey (SF-36;
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Ware & Sherbourne, 1992), the Brief Illness Perception Questionnaire (Brief IPQ; Broadbent, et
al., 2006), the Brief Coping Orientation to Problems Experienced Inventory (Brief COPE;
Carver, 1997; Muller & Spitz, 2003), the Illness Invalidation Inventory (3*1; Kool et al., 2010),
the Duke Activity Status Index (DASI; Hlatky & Mark, 1989), the State-Trait Anxiety Inventory
Y-1 form (STAI; Van der Ploeg, et al., 1980), and the Center for Epidemiologic Studies
Depression Scale- Revised (CESD-R; Radloff, 1977; Eaton, 2004).
Rehabilitation members were given the option to complete these assessments during one
interview session or two based on their personal preference. Upon having completed the
assessment paperwork, rehabilitation patients were provided feedback regarding their scores and
will be offered appropriate referrals and supportive services as deemed necessary. Upon having
completed the interview, all rehabilitation members were informed that they would be asked to
return to fill out the routine exit assessments required by the rehabilitation program upon
completion of the program.
Results
Preliminary Analyses
A total of 44 individuals were enrolled in the cardiac rehabilitation program located at the
USCA Wellness Center during data collection procedures. Of these 44 individuals, 25% were
women (n=10) and 75% were men (n=34). One hundred percent (n=44) of the individuals
reported their ethnicity as being Caucasian. The average age of participants was 72 years old,
with ages ranging from 58 to 88 years old and a standard deviation of 7.8. Of the 44 individuals
who entered the program, 75% reported attending the cardiac rehabilitation program after having
suffered a first-time cardiac event, and 25% reported having suffered one or more events prior to
rehab enrollment. In regards to event type, 25% reported having a coronary stent implanted, 23%
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reported having a heart attack, 21% reported having coronary artery bypass grafting, 16%
reported having suffered multiple events, 11% reported having a valve replaced, 2% reported
having bypass surgery, and 2% reported congestive heart failure. Demographic information
describing rehabilitation members can be found in Table 2.
Means, standard deviations, and other descriptive statistics for data collected at entrance
can be found in Table 3. IP, II, and Depression statistics were then organized by severity of
cardiac event, which can be found in Table 4. Correlations between all variables were
computed (Table 5). There was a strong, positive correlation between depression and IP,
r(44) = 0.52, p < 0.01. There was a moderate negative correlation between depression and
physical function, r(44) = - 0.47, p < 0.01. There was a moderate, positive correlation
between IP and II, r(44) = 0.48, p < 0.01, and a moderate, negative correlation between IP
and physical functioning, r(44) = - 0.41, p < 0.01. Lastly, there was a moderate, negative
correlation between II and physical functioning, r(44) = - 0.30, p < 0.05. Additionally,
Cronbach’s alpha was computed to determine the reliability of each measure (Table 6).
Thus revealed that the Brief COPE had an alpha of 0.49, the IPQ had an alpha of 0.86, the 3*I
had an alpha of 0.90, the SF-36 had an alpha of 0.82, and the CESD-R had an alpha of 0.92.
Hypothesis 1: Physical functioning will be predicted by IP, II, coping, and depression
scores.
To examine the extent to which physical functioning could be explained by the other
variables, physical functioning was regressed onto the four predictors simultaneously:
Positive coping, IP, invalidation, and depression (Table 7). The overall model was
significant, F(4,39) = 3.68, p = .012, R2 = .27, indicating that 27% of the variance in physical
functioning could be explained by the set of predictors. Inspection of each predictor
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individually revealed that only depression had a significant relationship with physical
functioning, B = -.90, p = .042. Specifically, each 1-unit increase in depression was
associated with a .90 decrease in physical functioning.
Hypothesis 2: Positive coping and low depression scores will strengthen the relationship
between invalidation and physical functioning and perception and physical functioning.
Results from Hypothesis 1 indicated that depression was the only significant predictor of
physical functioning. In order to investigate Hypothesis 2, four mediation tests were performed.
First mediation test
PROCESS (Hayes, 2013) was used in order to test whether coping mediated the
relationship between invalidation and physical functioning (Figure 1). The overall model
was not significant, F(1,42) = 1.32, p =0.26. The direct effect was not significant (B= -1.59,
95% CI = -3.24, 0.07, p = 0.06). However, this effect can be considered marginally significant
as the hypothesis is one-tailed. The indirect effect was not significant (B = -0.07, 95% CI = 0.45, 0.35).
Second mediation test
Next, the same procedure was used to test whether depression mediated the
relationship between invalidation and physical functioning (Figure 2). The direct effect was
not significant (B = 0.98, 95% CI = -2.54, 0.57, p = 0.21). The indirect effect was not
significant either (B = -0.67, 95% CI = -1.45, 0.29).
Third mediation test
Mediational analyses were performed using the same procedure in order to
determine whether coping mediated the effect of IP on physical functioning (Figure 3).
There was a significant direct effect (B = -0.75, 95% CI = -1.27, -.22, p = 0.01), indicating that
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higher IP was associated with lower physical functioning. However, the indirect effect
through positive coping was not significant (B = -0.01, 95% CI = -0.13, 0.08).
Fourth mediation test
Finally, the same procedure was used in order to examine whether depression
would mediate the relationship between IP and physical functioning (Figure 4). The direct
effect was not significant (B = -0.43, 95% CI = -1.00, 0.15, p = 0.14). Interestingly, the
indirect effect was indeed significant (B = -0.33, 95% CI = -0.70, -0.04).
Exploratory Analyses
II is defined as encompassing the perception of cognitive, affective and behavioral
responses of others that are perceived as denying, lecturing, overprotecting, not supporting
and not acknowledging with respect to the condition of the patient (Kool, 2012). This
definition suggests that II may be related to the patient’s perception of his or her illness in
reference to others’ perceptions. Thus, a second exploratory regression analysis was
performed in order to determine whether or not II was significantly related to IP (Table 8).
This analysis revealed that IP was significantly related to II in the cardiac rehabilitation
population (B =0.48, p = 0.00).
Lastly, based on these significant relationships between II and depression, IP and
depression, and II and IP, PROCESS was used in order to investigate whether or not II
mediated the relationship between IP and depression (Figure 5). This analysis revealed
that there was a significant direct effect (B = 0.33, 95% CI = 0.12, 0.54, p = 0.00), indicating
that higher IP was associated with higher depression scores. However, the indirect effect
through invalidation was approaching significance, but not significant (B = 0.02, 95% CI = 0.07, 0.21).
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Discussion
This study aimed to better understand the specific ways that II and IP are related to the
severity of physical symptoms in cardiovascular rehabilitation patients. More specifically, this
study examined the specific mechanisms involved in the relationship between II and physical
functioning in cardiac rehabilitation patients and the specific mechanisms involved in the
relationship between IP and physical functioning in cardiac rehabilitation patients. The present
study first used regression analyses in order to determine the extent to which II, IP, coping and
depression predicted physical functioning, and then by using PROCESS in order to identify
potential mediators in these relationships. Furthermore, given the lack of understanding of how
these relationships are mediated, the present study focused on how II and IPs are each
individually related to coping behaviors and depressive symptoms, and how those constructs
relate to patients’ physical functioning.
Coping
The first hypothesis that positive coping mechanisms would predict better physical
functioning in a cardiac rehabilitation population was not supported in the present study. These
results are contrary to previous research which has indicated that positive coping mechanisms
including problem and emotion focused coping are predictive of better physical functioning after
a cardiac trauma (Chiavarino et al., 2012). However, most of these studies have looked at
predictors of coronary heart disease in initially healthy samples and studied the development of
heart disease over time, whereas the present study utilized participants already diagnosed and in
rehabilitation for a heart condition. Thus, it is possible that participants in the present study may
have already implemented changes in lifestyle or cognitions upon diagnosis of their heart
condition; thus, the relationship between coping mechanisms and physical functioning during
recovery may be different than the initial relationship between coping mechanisms and physical

II AND IP IN THE CONTEXT OF CARDIOVASCULAR DISEASE

28

function during the development of the cardiac disease. This is consistent with previous literature
suggesting that the question of whether illness perceptions influence well-being via coping or
whether illness perceptions and coping each influence well-being independently should be
investigated in further, preferably with longitudinal studies (Kaptein et al., 2006).
It may also be the case that the presence of other psychosocial factors that were
unaccounted for in this study may influence the relationship between coping and physical
function. For example, hostility, optimism, and other personality characteristics may play a role
in physical health outcomes, and may also influence an individual’s style of coping (Shen et al.,
2003).
Sul and Fletcher (1985) found that active problem-focused coping was found to result in
more benign long-term outcomes following cardiac events, and Ali et al. (2010) found that
avoidant coping was associated with widespread psychological distress among cardiac patients,
including depression. In contrast, previous research indicates that using avoidance strategies to
cope soon (two to three weeks) after a stressor occurred has been associated with higher levels of
emotional distress (Dunkel-Schetter, Feinstein, Taylor, & Falke, 1992). Since measures were
only administered at the beginning of the cardiac rehab process, patients may have been using
those avoidant coping strategies for only a brief period of time, between when the cardiac trauma
occurred and entrance into rehabilitation. Future research collecting data upon completion of the
program may help to better illuminate effects of avoidant coping on physical functioning in
patients over a longer time frame.
Further, results of Hypothesis 2 indicated that coping was not predicted by invalidation or
IP. Thus, the expectation that positive coping strategies could be mediators in the relationships
between IP and physical functioning and II and physical functioning seems unlikely. In
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considering why coping strategies were not predicted by invalidation or IP, the self-regulation
model proposed by Leventhal (1997) may be relevant. The self-regulation model assumes that
health-related behavioral patterns such as coping strategies are a result of complex and
comprehensive representations of illness (Leventhal, 1997). In addition to how the patient
perceives the illness itself, multiple factors including the perceived consequences of the illness,
perceived causes, timeline, and cure or control of the illness all contribute to behaviors and
coping mechanisms an individual selects. It is also likely that an individual may not understand
his or her illness to the fullest extent, and thus may not be able to appropriately select an
effective coping strategy (Fan et al., 2013). Additionally, based on the significant relationship
between invalidation and perception, it is not unreasonable to consider the likelihood of these
numerous perception factors influencing an individual’s perceived invalidation from others,
which is consistent with the definition provided by Kool (2012) that invalidation encompasses
the perception of behavioral responses of others that are perceived as denying, lecturing,
overprotecting, not supporting, and not acknowledging the patient’s condition. Consequently,
coping strategies selected based on feelings of invalidation are unlikely to be consistent among
individuals who may perceive their illnesses differently. This is consistent with previous studies,
which suggest that patients plan and implement coping behaviors based on cognitive
representations and emotional responses to their illness (Fan et al., 2012).
However, based on the low Cronbach’s alpha reliability score of the Brief COPE, it is
most likely that the reason coping was not shown to be predictive of physical functioning, nor
related to any other constructs is due to the low reliability score of the measure itself. This low
score is likely a result of using an overall coping score rather than reporting subscale scores to
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look at different types of coping. Future studies should note this and adjust administration of the
measure accordingly.
Depression
As hypothesized, depression was significantly related to physical functioning in the
cardiac rehabilitation population. This is consistent with previous studies that have found a
significant relationship between depression and coronary heart disease (Carney et al., 2002;
Goldston & Baillie, 2008; Rugulies, 2002). Analyses revealed that depression was also a
significant mediator of the relationship between IP and physical functioning, which is consistent
with previous studies that indicate that IP is related to emotional distress, and that emotional
distress is related to depression (Arran et al., 2014; van den Broek et al., 2014). Meditational
analyses used to test Hypothesis 2 revealed that when depression was tested as a mediator of the
relationship between IP and physical functioning, the direct effect was not significant, but the
indirect effect was. This may suggest opposing processes, such that IPs may lead to
behaviors that increase physical functioning while simultaneously leading to depression,
which decreases physical functioning (Marayuma & Elliott, 2013). However, as shown in
Table 3, II, IP, and depression were all significantly associated with health outcomes, thus, the
probability of opposing processes is unlikely. Furthermore, the regression analysis for
Hypothesis 1 indicated that there was overlapping variation between the 3 constructs and that
depression was the strongest, which was also evident in mediation analyses.
The relationships between IP and depression, and between depression and physical
functioning were also significant. Thus, results indicate that IP was significantly related to
depression, and depression was significantly related to physical functioning. Therefore, an
individual’s physical functioning may be related to his or her perception of the illness. This

II AND IP IN THE CONTEXT OF CARDIOVASCULAR DISEASE

31

perception may be related to emotional distress, which may be related to reduced physical
functioning. This is consistent with findings from Hypothesis 1, which revealed that IP did not
significantly predict physical functioning in this cardiac rehabilitation sample. These
findings are contradictory to previous findings suggesting that IPs contribute directly to physical
health (Kaptein et al., 2006). However, previous findings also indicate that IPs affect physical
health via coping mechanisms (Fan et al., 2010).
An interesting finding is that when coping was tested as a mediator of the relationship
between IP and physical functioning, the direct effect was significant, but the indirect effect was
not. Thus, when coping was isolated as a mediator, IP was significantly related to physical
functioning. Thus, it may be important to consider isolating these constructs in future studies in
order to potentially identify causality and directionality.
Contradictory to Hypothesis 2, the prediction that depression would mediate the
relationship between invalidation and physical functioning was not supported. While considering
the relationships between invalidation, depression, and physical health, previous research
suggests that invalidation may impact physical health and social function but specific
mechanisms as to how these constructs relate have not been defined (Ghavidel-Parsa et al.,
2014).
However, while depression did not significantly mediate the relationship between
invalidation and physical functioning, the relationship between invalidation and depression was
significant, as was the relationship between depression and physical functioning. Thus, it is
likely that an individual may have lower physical functioning if (s)he feels invalidated about his
or her illness, and this invalidation may be related to emotional distress, including depressive
symptoms, which are related to reduced physical functioning.
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Additionally, in regards to II, predictions of Hypothesis 1 that invalidation would
significantly predict physical functioning were not supported. These results are
contradictory to previous research suggesting that invalidation is significantly correlated with
symptom severity and health status (Ghavidel-Parsal et al., 2014). However, to our knowledge,
previous studies have investigated invalidation in the context of fibromyalgia and rheumatology
(Ghavidel-Parsa et al., 2014; Kool, 2012) and this is the first study to investigate invalidation in
relation to cardiac disease. Previous research has also separated invalidation into more specific
constructs including discounting and lack of understanding, while this study used a total
invalidation score. In addition, while previous research indicates that emotional distress is
associated with lower physical functioning in cardiac patients (Hoogwegt et al., 2014). However,
if a patient does not experience emotional distress as a result of invalidation, he or she may not
experience a reduction in physical functioning. Thus, it may be possible that some patients can
experience II, but may manage that invalidation in a way that does not result in emotional
distress.
Lastly, a regression analysis was performed in order to determine if II may be
related to the patient’s perception of his or her illness revealed that IPs are significantly
related to II. Thus, the worse an individual perceives an illness to be, the more likely it is
that this will be related to higher feelings of invalidation from others. The opposite may be
true as well, as it is possible that invalidation may be related to illness perceptions. Future
studies should investigate directionality in this relationship. Consistent with previous
findings in the present study, this suggests that IP and II are both related to depression.
Due to the significant relationships between IP and II, II and depression, and IP and
depression, a mediation analysis was performed in order to determine if II might mediate
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the relationship between IP and depression. This relationship was not found to be
approaching significance.
Strengths and Limitations
First, this study used PROCESS in order to investigate the interrelationships among
multiple variables that, to our knowledge, have not been previously connected in the health
literature. Additionally, to the best of our knowledge, this was the first study to investigate the
construct of illness invalidation in relation to a cardiac rehabilitation population, as almost all
previous studies have examined II in relation to rheumatology diseases. Likewise, it is the first of
its kind to investigate IP in a cardiac setting, and the relationship between IP, depression, and
physical health can prove extremely beneficial in future health interventions.
Although there were several novel findings within the present study, there were also
several limitations, which should be addressed in future studies. One limitation was the
demographic composition, which had very little variability. For example, the sample was
comprised of 44 participants enrolled in a cardiac rehabilitation program located in a small
southeastern community, and thus may not be fully representative of the full range of beliefs and
experiences of those differing geographic regions or with different medical diagnoses. It should
also be noted that the sample size was relatively small with only 44 participants, who were
mostly white males of high socioeconomic status. While the results of the present study may be
generalizable to populations with similar demographic composition who have experienced a
cardiac event, caution should be taken in generalizing the results to other types of medical illness
or the larger population due to representativeness issues. Thus, future studies should make a
more determined effort to increase the number of racially diverse participants as it is necessary to
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determine whether patterns established in the empirical findings in the present study may pertain
more so to non-minorities than they do to minorities.
Additionally, due to the nature of the cardiac rehabilitation population, it is likely that the
sample did not include individuals who were employing completely avoidant coping strategies,
as all individual enrolled in the program were implementing some level of active coping by
attending the program. Thus, it is likely that the sample did not include patients with a
completely avoidant style of coping.
It is possible that participants may not have responded in a forthright manner given that
measures were first completed upon entrance into the program, when participants may have felt
particularly self-conscious about their physical abilities or symptoms of distress. Participants also
reported feeling overwhelmed with the amount of measures administered, and thus may not have
taken the time to answer honestly and accurately. Therefore, future research may benefit from
the use of alternative measurement techniques, such as personal interviews, administered over a
period of days rather than all at once. With this said, however, participants provided information
voluntarily and had the option to leave blank any question or form they felt uncomfortable
answering. Thus, this limitation is not seen as particularly problematic, given that data was
collected through standard protocol, as utilized by the cardiac rehabilitation program.
Finally, another limitation relates to the fact that previous non-cardiac traumas were not assessed
for in the context of constructs examined. While all individuals in the present study share a
cardiac history, it should be noted that we cannot rule out the effects of other potential traumas or
stressors on reports of physical functioning or the overall findings.
Summary and Conclusions

II AND IP IN THE CONTEXT OF CARDIOVASCULAR DISEASE

35

In conclusion, this study provided an in-depth examination of the characteristics
associated with and predictive of physical functioning in a cardiac rehabilitation sample. To the
best of our knowledge, this was the first study to examine the relationships between II, IP,
coping mechanisms, depression, and physical functioning together. Previous studies indicated
that all of these constructs may be related, but the specific mechanisms were not clear. The
present study used a regression analysis to reveal that depression was the only significant
predictor of physical functioning, and that II, IP, and coping were not. The present study also
used PROCESS to reveal that depression mediated the relationship between IP and physical
functioning, but did not mediate the relationship between II and physical functioning. The
present study failed to find evidence that coping mediated the relationship between IP and
physical functioning, nor did coping mediate the relationship between II and physical
functioning. The present study also revealed that IP and II were significantly related to
depression, and that IP was significantly related to II. Thus, the present study suggests that II, IP,
depression, and physical functioning are all related. Findings indicate that the more threatening a
patient perceives an illness to be is related to the patient experiencing more depressive
symptoms. The study also suggests that the more depressive symptoms a patient experiences is
related to the patient experiencing a reduction in physical functioning. Findings also imply that
the more threatening a patient perceives an illness to be is related to the patient experiencing
invalidation from others about his or her illness. Lastly, the present study suggests that the more
invalidated a patient feels in relation to his or her illness is related to the depressive symptoms
the patient experiences as well. Thus, II, IP, and depression all clearly play an important
functional role in the maintenance of physical functioning in a cardiac rehabilitation population.
Implications and Directions for Future Research
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While all predictions of the study were not fully supported, the present study did reveal
some interesting findings. First, results from the present study have better illuminated how the
constructs of depression, coping, II, IP, and physical function are related. While the present study
did not support the prediction that II, IP, and coping would each predict physical functioning,
these results may indicate that these constructs are more closely related to physical functioning
during development of disease, rather than after the patient has already entered a rehabilitation
program. This is especially important for future health interventions, as findings indicate that
these constructs may only be predictive of physical health before a detrimental health even
occurs. These results also indicated that not only is depression related to physical functioning as
indicated in previous literature (Carney et al., 2002; Rugulies, 2002), but illuminates the
interrelationships among other variables that are related to depression and physical functioning
as well. IP and II were both found to be related to depression, which is related to physical
functioning, and IP was related to II. This is especially important in development of future
treatment plans, as focusing on not only the patient’s perception of his or her illness, but how
that perception may contribute to feelings of invalidation or depressive symptoms that may
contribute to the patient’s overall health. Additionally, it may be beneficial to include behavioral
observation of the patient with his or her support system in order to objectively observe the
degree of invalidation.
Given these different associations between II and IP and physical functioning, the use of
strategies aimed at teasing apart causal relationships among these variables may help increase
physical functioning in cardiac rehab patients. For example, working with patients’ significant
others and families in order to help them better understand the patient’s illness and symptoms,
and also educating them about how invalidation my manifest physically, as is also likely that an
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individual may not understand his or her illness to the fullest extent, and thus may not be able to
appropriately select an effective coping strategy (Kool, 2012; Fan et al., 2013). Lastly, future
methods should also assess individuals’ perception of the illness in a more in-depth manner, as
perception is likely influenced by numerous factors unaccounted for in this study.
In addition to treatment related suggestions, methodological suggestions for future
research are important to consider as well. It may be relevant to separate the physical functioning
construct into objective health measures (BMI, heart rate, and systolic blood pressure), and the
SF-36, which is a more subjective measure. It would also be important to administer only the
active coping items on the Brief COPE rather than administering all items and generating an
overall coping score. Additionally, it would be helpful to obtain data from a more diverse
rehabilitation population in order to create a more generalizable result. It would also be ideal to
collect data on patients before a cardiac trauma occurs or the patient is diagnosed with a cardiac
disease, in order to determine the extent to which, if any, coping, depression, II, and IP predict
the development of a cardiac trauma or cardiac disease. Lastly, future research may benefit from
using a sample of all individuals diagnosed with a cardiac disease, rather than simply those who
attend cardiac rehabilitation in order to achieve a more accurate representation of the population,
as individuals who attend cardiac rehabilitation already have achieved a somewhat active level of
coping since they are in a program designed to help them recover from and manage their disease.
It would also be beneficial to make more of an effort to help patients understand the purpose of
the measures so that they may be more likely to respond in a more truthful and forthright
manner.
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Table 1
Summary of Intercorrelations of Physical Variables
1

2

3
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1. SF-36

---

---

---

2. Heart Rate

-0.51**

---

---

3. BMI

-0.63**

0.65*

---

4. Blood Pressure

-0.57*

0.96*

0.54*
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Note: *p <.05,**p <.01.

Table 2
Participant Demographics (N=44)
Variables

n

Percent
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Table 2
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Table 3
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Table 4
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Summary of Regression Predicted by Severity of Event
Variable
Depression
Coping
Invalidation
Perception
R2
F-value

B

SE (B)

β

0.79
0.45
0.91
1.58

1.92
0.24
0.94
2.80
.07
3.36*

0.06
0.27
0.15
0.09

Note: *p < .05; Event severity was separated into three categories that were used as predictors: Category 1: Other,
stent; Category 2: MI, CHF; Category 3: CABG, multiple events

Table 5
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Summary of Intercorrelations of Variables
1
---

2
---

3
---

4
---

2. Depression

0.15

---

---

---

3. IP

0.06

0.52**

---

---

4. Invalidation

0.18

0.29

0.48**

---

5. Physical Function

-0.12

-0.47**

-0.41**

-0.30*

1. Positive Coping

Note: *p <.05,**p <.01.

Table 6
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Summary of Reliability Statistics for Measures
1. Brief COPE

Cronbach’s Alpha
0.49

2. IP

0.86

3. Invalidation

0.90

2. SF-36

0.82

3. CESD-R

0.92

Table 7
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Summary of Regression Analysis: Predicting for Physical Functioning
Variable
Depression
Coping
Invalidation
Perception
R2
F-value
Note: *p < .05, **p < .01.

B

SE (B)

β

-0.90
-0.76
-0.58
-0.34

0.04
2.50
0.86
0.32
.27
3.68*

-0.34*
-0.19
-0.11
-0.19
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Table 8
Summary of Regression Analysis: Predicting for II
Variable
Perception
R2
F-value
Note: *p < .05, **p < .01.

B
0.16

SE (B)
0.46
0.21
12.6**

β
0.48**
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Figure 1: Coping as a mediator of the relationship between II and physical function

Note: *p < .05; **p < .01. Effects of increased invalidation on physical function through the potential mediator of
coping; coefficients are unstandardized estimates and the coefficient in parentheses is the total effect.
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Figure 2: Depression as a mediator of the relationship between II and physical function

Note: *p < .05; **p < .01. Effects of increased invalidation on physical function through the potential mediator of
depression; coefficients are unstandardized estimates and the coefficient in parentheses is the total effect.
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Figure 3: Coping as a mediator of the relationship between IP and physical function

Note: *p < .05; **p < .01. Effects of worse IP on physical function through the potential mediator of coping;
coefficients are unstandardized estimates and the coefficient in parentheses is the total effect.

II AND IP IN THE CONTEXT OF CARDIOVASCULAR DISEASE

57

Figure 4: Depression as a mediator of the relationship between IP and physical function

Note: *p < .05; **p < .01. Effects of worse IP on physical function through the potential mediator of depression;
coefficients are unstandardized estimates and the coefficient in parentheses is the total effect.
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Figure 5: II as a mediator of the relationship between IP and depression

Note: *p < .05; **p < .01. Effects of worse IP on depression through the potential mediator of invalidation;
coefficients are unstandardized estimates and the coefficient in parentheses is the total effect.
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Appendix A
Demographics Questionnaire
Please answer the following questions to the best of your ability.
What is your gender?
Male Female
What is your race/ethnicity?
Caucasian
African American
Asian
Other
What is your current marital status?
Single
Married
Divorced
Widowed
Separated
What is your current employment status?
Employed
Unemployed
Retired
Unable to work
What is your current annual household income?
$0 – 19,999
$20 – 39,999
$40 – 59,999
$60 – 79,999
$ 80,000+
N/A
Please describe your cardiac event that brought you to the cardiac rehabilitation program:
______________________________________________________________________________
__________________________________________________________________
______________________________________________________________________________
__________________________________________________________________
______________________________________________________________________________
__________________________________________________________________
______________________________________________________________________________
__________________________________________________________________
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Have you ever attended cardiac rehabilitation in the past?
No previous rehabilitation
Yes, completed previous rehabilitation program
Yes but dropped out
Have you ever had a previous cardiac event?
No, no previous event
Yes, cardiac history
If yes, please describe:
______________________________________________________________________________
__________________________________________________________________
______________________________________________________________________________
__________________________________________________________________
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Appendix C
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Appendix D
Brief IPQ
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Appendix E
Brief COPE
These items deal with ways you've been coping with the stress in your life since you found out you were
going to have to have this operation. There are many ways to try to deal with problems. These items ask
what you've been doing to cope with this one. Obviously, different people deal with things in different
ways, but I'm interested in how you've tried to deal with it. Each item says something about a particular
way of coping. I want to know to what extent you've been doing what the item says. How much or how
frequently. Don't answer on the basis of whether it seems to be working or not—just whether or not you're
doing it. Use these response choices. Try to rate each item separately in your mind from the others. Make
your answers as true FOR YOU as you can.
1 = I haven't been doing this at all
2 = I've been doing this a little bit
3 = I've been doing this a medium amount
4 = I've been doing this a lot
1. I've been turning to work or other activities to take my mind off things.
2. I've been concentrating my efforts on doing something about the situation I'm in.
3. I've been saying to myself "this isn't real.".
4. I've been using alcohol or other drugs to make myself feel better.
5. I've been getting emotional support from others.
6. I've been giving up trying to deal with it.
7. I've been taking action to try to make the situation better.
8. I've been refusing to believe that it has happened.
9. I've been saying things to let my unpleasant feelings escape.
10. I’ve been getting help and advice from other people.
11. I've been using alcohol or other drugs to help me get through it.
12. I've been trying to see it in a different light, to make it seem more positive.
13. I’ve been criticizing myself.
14. I've been trying to come up with a strategy about what to do.
15. I've been getting comfort and understanding from someone.
16. I've been giving up the attempt to cope.
17. I've been looking for something good in what is happening.
18. I've been making jokes about it.
19. I've been doing something to think about it less, such as going to movies, watching
daydreaming, sleeping, or shopping.
20. I've been accepting the reality of the fact that it has happened.
21. I've been expressing my negative feelings.
22. I've been trying to find comfort in my religion or spiritual beliefs.
23. I’ve been trying to get advice or help from other people about what to do.
24. I've been learning to live with it.
25. I've been thinking hard about what steps to take.
26. I’ve been blaming myself for things that happened.
27. I've been praying or meditating.
28. I've been making fun of the situation.

TV, reading,
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Appendix F
Illness Invalidation Inventory
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Appendix G
Duke Activity Status Index
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Appendix H
State Trait Anxiety Inventory form Y-2
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